Time to Rethink the Role of Clinical Pathways in the Era of Precision Medicine: A Lung Cancer Case Study-Reference-Cited by-同舟云学术

Time to Rethink the Role of Clinical Pathways in the Era of Precision Medicine: A Lung Cancer Case Study

Published:2021-07 Issue:7 Volume:17 Page:379-381
ISSN:2688-1527
Container-title:JCO Oncology Practice
language:en
Short-container-title:JCO Oncology Practice

Author:

Schleicher Stephen M.¹²^ORCID,Chaudhry Basit³^ORCID,Dickson Natalie R.¹²^ORCID,Aviki Emeline⁴^ORCID,Arrowsmith Edward¹²,Parikh Ravi B.⁵⁶^ORCID,Yue Andrew T.³^ORCID,Connor Nora³^ORCID,Schwartzberg Lee²⁷^ORCID,Lyss Aaron J.²^ORCID

Affiliation:

1. Tennessee Oncology, Nashville, TN

2. OneOncology, Nashville, TN

3. Tuple Health, Washington, DC

4. Memorial Sloan Kettering Cancer Center, New York, NY

5. Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA

6. Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA

7. West Cancer Center, Memphis, TN

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Oncology (nursing),Health Policy,Oncology

Link

https://ascopubs.org/doi/pdfdirect/10.1200/OP.21.00073

Reference7 articles.

1. Oncology Clinical Pathways: Charting the Landscape of Pathway Providers

2. Cost Effectiveness of Evidence-Based Treatment Guidelines for the Treatment of Non–Small-Cell Lung Cancer in the Community Setting

3. Cost and Survival Analysis Before and After Implementation of Dana-Farber Clinical Pathways for Patients With Stage IV Non–Small-Cell Lung Cancer

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Data Science and Precision Oncology Nursing: Creating an Analytic Ecosystem to Support Personalized Supportive Care across the Trajectory of Illness;Seminars in Oncology Nursing;2023-06

2. Impact of clinical pathways on treatment patterns and outcomes for patients with non-small-cell lung cancer: real-world evidence from a community oncology practice;Journal of Comparative Effectiveness Research;2022-06

3. Missing the target: The oncology care model treatment pricing scheme is prohibitively reductive for gynecologic malignancies;Gynecologic Oncology;2022-04

4. Oncology alternative payment models: lessons from commercial insurance;The American Journal of Managed Care;2022-03-01

5. Affirming the Value of Clinical Chemotherapy Pathways Programs;JCO Oncology Practice;2021-08